Emergent BioSolutions (EBS) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$105.2 million.
- Emergent BioSolutions' Retained Earnings rose 4191.05% to -$105.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.2 million, marking a year-over-year increase of 4191.05%. This contributed to the annual value of -$212.4 million for FY2024, which is 87431.19% down from last year.
- Emergent BioSolutions' Retained Earnings amounted to -$105.2 million in Q3 2025, which was up 4191.05% from -$156.4 million recorded in Q2 2025.
- Over the past 5 years, Emergent BioSolutions' Retained Earnings peaked at $954.1 million during Q1 2022, and registered a low of -$295.9 million during Q2 2024.
- For the 5-year period, Emergent BioSolutions' Retained Earnings averaged around $339.5 million, with its median value being $289.7 million (2023).
- Its Retained Earnings has fluctuated over the past 5 years, first soared by 9462.5% in 2021, then tumbled by 102812.5% in 2025.
- Quarter analysis of 5 years shows Emergent BioSolutions' Retained Earnings stood at $950.3 million in 2021, then dropped by 22.27% to $738.7 million in 2022, then plummeted by 102.95% to -$21.8 million in 2023, then plummeted by 874.31% to -$212.4 million in 2024, then skyrocketed by 50.47% to -$105.2 million in 2025.
- Its Retained Earnings was -$105.2 million in Q3 2025, compared to -$156.4 million in Q2 2025 and -$144.4 million in Q1 2025.